Conclusions Are Not Supported by the Published Statistical Analysis. Comment on López-Toledo et al. Flaxseed Improves Glucose and Lipid Metabolism in Mexican Subjects with Type 2 Diabetes: A Parallel Randomized Clinical Trial. Nutrients 2025, 17 , 709...Lopez-Toledo S, Pineda De la Cruz MC, Gutirrrez-Hurtado IA et al.

The article focuses on a randomized clinical trial by López-Toledo et al. that examined the effects of flaxseed powder on biochemical markers in adults with uncontrolled Type 2 diabetes. The study suggested that consuming 16 g of flaxseed daily for three months may lower glucose, total cholesterol,...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrients Vol. 18; no. 1; pp. 170 - 172
Autores principales: Spitz, Robert W., Thapa, Deependra K., Mokalla, Thirupathi Reddy, Najam, Wasiuddin, Brown, Andrew W., Allison, David B.
Formato: commentary letter Journal Article
Publicado: MDPI Jan2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=190788167&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 190788167
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726643
        B0TT
      jtl: Nutrients
      issn: 20726643
      maglogo: N
    pubinfo:
      dt: Jan2026
      vid: 18
      iid: 1
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        190788167
        190788167
        190788167
        10.3390/nu18010170
        190788167
      ppf: 170
      ppct: 2
      formats:
      tig:
        atl: Conclusions Are Not Supported by the Published Statistical Analysis. Comment on López-Toledo et al. Flaxseed Improves Glucose and Lipid Metabolism in Mexican Subjects with Type 2 Diabetes: A Parallel Randomized Clinical Trial. Nutrients 2025, 17 , 709...Lopez-Toledo S, Pineda De la Cruz MC, Gutirrrez-Hurtado IA et al.
      aug:
        au:
          Spitz, Robert W.
          Thapa, Deependra K.
          Mokalla, Thirupathi Reddy
          Najam, Wasiuddin
          Brown, Andrew W.
          Allison, David B.
        affil: Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39216, USA
      sug:
        subj:
          Flaxseed Administration and Dosage
          Blood Glucose Metabolism
          Lipids Metabolism
          Mexicans
          Diabetes Mellitus, Type 2 Diet Therapy
          Glycemic Control
          Diabetic Patients
          Metformin Therapeutic Use
          Diabetes Mellitus, Type 2 Drug Therapy
          Cholesterol Blood
          Triglycerides Blood
      ab: The article focuses on a randomized clinical trial by López-Toledo et al. that examined the effects of flaxseed powder on biochemical markers in adults with uncontrolled Type 2 diabetes. The study suggested that consuming 16 g of flaxseed daily for three months may lower glucose, total cholesterol, and triglyceride levels. However, the authors highlight a methodological concern regarding the use of within-group comparisons to draw conclusions about between-group differences, which can lead to a DINS (Difference in Nominal Significance) error and inflate the type I error rate. They emphasize the need for more robust statistical methods, such as ANCOVA, to ensure accurate comparisons and reproducibility of results.
      pubtype: Academic Journal
      doctype:
        commentary
        letter
        Journal Article
      ougenre: Unknown
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N